Menu
Live News EQUITY L impact

NSRX: CEO Buys 6,550 Shares

Nasus Pharma CEO Dan Benjamin Teleman buys 6,550 shares at $3.1

NSRX

FORM 4P NSRX - Nasus Pharma Ltd*|DIRECTOR|OFFICER - Chief Executive Officer: Teleman Dan BenjaminP | 6,550 | $3.1 | $20,305